|About Us||Patients, Families & Visitors||For Health Professionals||Careers||Research & Training||Ways to Give|
In North America, prostate cancer has become the most commonly diagnosed cancer in men. It is responsible for 4300 deaths each year in Canada alone.
Education and research are the keys to success in the diagnosis and treatment of prostate disease.
London’s medical community is a national leader in research. We also have many physicians who specialize in the management of prostate cancer.
In September 2002, Robert Hardie, a researcher in the Division of Urology at London Health Sciences Centre (LHSC), donated $1 million to create a research chair position to study urologic cancers. The Robert Hardie Translational Prostate Cancer Research Laboratory focuses on the translational aspects of cancer research.
The Translational Prostate Cancer Research Group’s purpose is to foster an environment where fundamental cancer researchers, surgeons, and clinical researchers work together. As a team, we can quickly transfer research discoveries from the "bench to the bedside" and make real advances in prostate cancer control.
Our key objective is to equip future researchers with the skills to work on the threshold between discovery and applied research. Whether new discoveries begin at the bedside or the bench, our overall goal is to understand and eventually conquer prostate cancer.
The research program concentrates on two of the most deadly aspects of prostate cancer. The first is early stage prostate cancer detection using nanotechnology in a non-invasive way. The second is the study of metastasis. Ninety percent of mortalities from prostate cancer are due to the escape of cancer cells from the prostate that spread to distant sites like the bones.
The Translational Prostate Cancer Research Group also trains medical students and clinical fellows. Our goal as a teaching facility is to help new clinicians understand the science behind the development of new therapies for cancer, and to help bring knowledge and passion for research to their clinical practices.
We regularly hold multidisciplinary team meetings to discuss patient care, research issues, and clinical trials. The group also holds telehealth meetings with specialists in geographically remote locations, and holds weekly citywide rounds to discuss complex cases.
Below The Belt Newsletter published by the London Prostate Cancer Centre, a joint initiative of LRCP, Lawson Health Research Institute, London Health Sciences Centre, St. Joseph’s Health Care, and the University of Western Ontario, this newsletter keeps healthcare professionals abreast of the latest developments in prostate cancer research and treatment.
You can access pdf versions of the newsletter by clicking the following:
Events Supporting Prostate Cancer Research